← Leaderboards
Anita D'souza
Medical College Of Wisconsin
$1,635,665
Attributed
$2,074,228
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $930.8K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,074,228 · 3
By mechanism
R01$1,476,844 · 2
K23$597,384 · 1
Top collaborators
- Patricia Maureen Sheean1 shared
- Melinda R Stolley1 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Raymond Quezon Migrino$1,515,059
- Anjishnu Banerjee$362,415
- Reza Shaker$77,917,775
- Patricia Maureen Sheean$1,691,647
- Ling Mei$460,963
Others in their field
Other Emerging Leaders on “Diagnosis”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$337,858,596
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$141,100,782
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedmand · Leidos Biomedical Research, Inc.$66,248,714
Research focus
DiagnosisSpecialistMultiple MyelomaChemotherapySymptomsOrganResponsePlasma CellsMethodologyLightMortalityAmyloidosisDepositionValidationClinical ResearchMorbidity - Disease RatePrimary Amyloidosis Of Light Chain TypeCardiacAmyloidFunctional DisorderAmyloid FibrilsOncologyNovel TherapeuticsMultidisciplinary
Grant awards (8)
Moving Forward with Multiple Myeloma$657,844
R01 · FY2025 · CA
Early diagnosis of light chain amyloidosis$273,000
R01 · FY2025 · HL · contact PI
Early diagnosis of light chain amyloidosis$273,000
R01 · FY2024 · HL · contact PI
Early diagnosis of light chain amyloidosis$273,000
R01 · FY2023 · HL · contact PI
Development and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosis$139,456
K23 · FY2022 · HL · contact PI
Development and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosis$151,688
K23 · FY2021 · HL · contact PI
Development and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosis$153,660
K23 · FY2020 · HL · contact PI
Development and validation of a disease-relevant patient-reported outcome tool in light chain amyloidosis$152,580
K23 · FY2019 · HL · contact PI